Vote Scores
Filings read through

Teva Pharmaceutical Industries Limited: how funds voted at the meeting of 6 Jun 2024

Ticker
TEVA
Meeting
Season
year to 30 June 2024
Filers reporting
567
Ballot items
5

567 filers on Form N-PX reported votes at the Teva Pharmaceutical Industries Limited meeting of 6 Jun 2024. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Teva Pharmaceutical Industries Limited has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    4 nominees. 87.3% of the reported votes are for. 32 filers withheld from or voted against at least one nominee.

    798 vote records from 113 filers. 15 of the 112 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 37 fund families
    • For 33
    • Against 2
    • Split or no vote 2
    • Against management 2
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    757 vote records from 554 filers. 57 of the 533 filers that marked the item voted against management. 21 filers gave no management mark.

    0 filers reported share counts too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 47 fund families
    • For 43
    • Against 4
    • Against management 4
  3. Item 3: Frequency of the say-on-pay vote

    One year: 467 filers. For: 19 filers. Three years: 14 filers. Take no action: 8 filers. Abstain: 6 filers. 1-year: 5 filers.

    814 vote records from 548 filers. 18 of the 524 filers that marked the item voted against management. 24 filers gave no management mark.

    0 filers reported share counts too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 47 fund families
    • For 1
    • Split or no vote 46
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    199 vote records from 112 filers. 4 of the 111 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 37 fund families
    • For 35
    • Against 1
    • Split or no vote 1
    • Against management 1
  5. Item 5: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    4 vote records from 2 filers. 0 of the 2 filers that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Teva Pharmaceutical Industries Limited, meeting of 6 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinForSplitFor
AllspringForSplitNo report
American CenturyForSplitFor
BairdForSplitNo report
BlackRock and iSharesForSplitFor
BNY MellonForSplitFor
Brighthouse FundsForSplitFor
Capital Group and American FundsForSplitFor
Charles SchwabForSplitFor
Columbia ThreadneedleAgainst, against managementSplitNo report
DimensionalForSplit, against managementFor
DWSForSplitFor
EquitableForSplitFor
FidelityForSplitFor
First TrustForSplitFor
Franklin TempletonForSplitNo report
Goldman SachsForSplitFor
Guggenheim and RydexForSplitFor
Hartford FundsForSplitNo report
InvescoForSplitFor
J.P. MorganForForSplit
Jackson National fundsForSplit, against managementFor
Janus HendersonForSplitNo report
John Hancock and ManulifeForSplitFor
Macquarie and Delaware FundsForSplitNo report
MassMutualForSplitNo report
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplitFor
NationwideForSplitFor
Natixis and Loomis SaylesForSplitFor
Neuberger BermanForSplitFor
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsForSplitFor
PGIM and PrudentialForSplitFor
PIMCOAgainst, against managementSplitAgainst, against management
PrincipalForSplitFor
Russell InvestmentsForSplitNo report
SEIForSplitFor
State Street and SPDRAgainst, against managementSplitFor
T. Rowe PriceForSplitFor
ThriventForSplitFor
TransamericaForSplitFor
VanEckForSplitFor
VanguardForSplitNo report
Victory CapitalForSplitFor
VoyaForSplitFor
WisdomTreeForSplitFor

Questions

How many filers reported votes at the Teva Pharmaceutical Industries Limited meeting?
567 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 57 of 533 filers that marked the item voted against management (10.7%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Teva Pharmaceutical Industries Limited reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Teva Pharmaceutical Industries Limited with a meeting date within three days of 6 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .